Common use of Drug Testing Standards Clause in Contracts

Drug Testing Standards. A. Screening Test Standards: The following initial immunoassay test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs: Cocaine metabolites 300 ng/ml Opiate metabolites 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1000 ng/ml B Confirmatory Test Standards: All specimens identified as positive on the initial screening tests shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Concentrations which exceed the linear region of the standard curve shall be documented. Marijuana metabolites1 15 ng/ml Cocaine metabolites2 150 ng/ml Opiates: Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines: Amphetamine 500 ng/ml Methamphetamine 500 ng/ml 1Delta-9-tetrahydrocannabinol-9-carboxylic acid 2Benzoylecgonine

Appears in 3 contracts

Sources: Collective Bargaining Agreement, Collective Bargaining Agreement, Collective Bargaining Agreement

Drug Testing Standards. A. (A) Screening Test Standards: . The following initial immunoassay test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs: Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1000 ng/ml B (B) Confirmatory Test Standards: . All specimens identified as positive on the initial screening tests test shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Concentrations which exceed the linear region of the standard curve shall be documented. Marijuana metabolites1 15 ng/ml Confirmatory Cocaine metabolites2 metabolites 150 ng/ml Opiates: Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines: Amphetamine 500 ng/ml Methamphetamine 500 ng/ml 1Delta-9*Delta-9-tetrahydrocannabinol-9-carboxylic acid 2Benzoylecgonine**Benzoylecgonine

Appears in 1 contract

Sources: Collective Bargaining Agreement

Drug Testing Standards. A. Screening Test Standards: The following initial immunoassay test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs: Cocaine metabolites 300 ng/ml Opiate metabolites 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1000 ng/ml B Confirmatory Test Standards: All specimens identified as positive on the initial screening tests shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Concentrations which exceed the linear region of the standard curve shall be documented. Confirmatory Test Level Marijuana metabolites1 15 ng/ml Cocaine metabolites2 150 ng/ml Opiates: Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines: Amphetamine 500 ng/ml Methamphetamine 500 ng/ml 1Delta-9-tetrahydrocannabinol-9-carboxylic acid 2Benzoylecgonine

Appears in 1 contract

Sources: Collective Bargaining Agreement